Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 646,400 | 901,900 | 278,893 | 266,586 | 441,702 |
| Marketable Securities | 188,200 | 46,700 | 713,698 | 701,039 | 563,748 |
| Receivables | 1,700 | 13,100 | 1,236 | 27,584 | 369 |
| Inventories | 37,100 | 32,000 | 29,184 | 35,589 | 30,933 |
| TOTAL | $1,082,700 | $1,247,100 | $1,242,004 | $1,249,874 | $1,218,792 |
| Non-Current Assets | |||||
| PPE Net | 121,400 | 116,300 | 111,403 | 106,381 | 98,810 |
| Investments And Advances | 0 | 0 | 0 | 0 | 545 |
| Intangibles | 0 | 0 | 0 | 2,137 | 2,082 |
| Other Non-Current Assets | 392,600 | 370,300 | 359,541 | 331,522 | 295,420 |
| TOTAL | $514,000 | $486,600 | $470,944 | $440,040 | $396,857 |
| Total Assets | $1,596,700 | $1,733,700 | $1,712,948 | $1,689,914 | $1,615,649 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 266,000 | 319,100 | 142,873 | N/A | N/A |
| Accounts payable and accrued liabilities | 204,500 | 278,400 | 249,638 | 214,197 | 174,953 |
| Other current liabilities | 7,100 | 12,300 | 23,579 | 33,829 | 40,070 |
| TOTAL | $509,100 | $636,400 | $433,572 | $265,482 | $234,373 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 171,930 | 310,264 | 305,745 |
| Other Non-Current Liabilities | 119,900 | 95,200 | 96,186 | 78,629 | 57,782 |
| TOTAL | $119,900 | $95,200 | $268,116 | $388,893 | $363,527 |
| Total Liabilities | $629,000 | $731,600 | $701,688 | $654,375 | $597,900 |
| Shareholders' Equity | |||||
| Common Shares | 100 | 100 | 37 | 37 | 37 |
| Retained earnings | 967,600 | 1,002,000 | 1,011,223 | 1,035,502 | 1,017,712 |
| TOTAL | $967,700 | $1,002,100 | $1,011,260 | $1,035,539 | $1,017,749 |
| Total Liabilities And Equity | $1,596,700 | $1,733,700 | $1,712,948 | $1,689,914 | $1,615,649 |